Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report

被引：0
|
作者：
Danielle Delombaerde
Delphine Vervloet
Dieter Berwouts
Roel Beckers
Hans Prenen
Marc Peeters
Félix Gremonprez
Lieselot Croes
Christof Vulsteke
机构：
[1] AZ Maria Middelares,Integrated Cancer Center Ghent, Department of Medical Oncology
[2] University of Antwerp,Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON)
[3] AZ Maria Middelares,Department of Cardiology
[4] AZ Maria Middelares,Department of Nuclear Medicine
[5] AZ Maria Middelares,Department of Radiology
[6] Antwerp University Hospital,Multidisciplinary Oncologic Centre Antwerp (MOCA)
来源：
Journal of Medical Case Reports | / 16卷
关键词：
Myocarditis; Immune-related adverse events; Dual checkpoint inhibition; Cholangiocarcinoma; Case report;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report
    Delombaerde, Danielle
    Vervloet, Delphine
    Berwouts, Dieter
    Beckers, Roel
    Prenen, Hans
    Peeters, Marc
    Gremonprez, Felix
    Croes, Lieselot
    Vulsteke, Christof
    JOURNAL OF MEDICAL CASE REPORTS, 2022, 16 (01)
  • [2] A BROKEN HEART: A CASE OF IPILIMUMAB AND NIVOLUMAB-INDUCED MYOCARDITIS
    Chacon, Daniel
    Heydari-Kamjani, Milad
    Cragnotti, Giovanni
    Pendlebury, David
    Conley, Sean
    Sonnino, Alice
    Placido, Jenny
    Koppikar, Maekhila
    CHEST, 2024, 166 (04) : 309A - 310A
  • [3] Nivolumab-induced fatal myocarditis: A case report
    Bharathidasan, Kavya
    Abdelnabi, Mahmoud
    Abdelmalek, John
    Sekhon, Jasmine
    Butler, William
    Quirch, Miguel
    Sosa, Erwin Argueta
    CLINICAL CASE REPORTS, 2023, 11 (05):
  • [4] Ipilimumab and Nivolumab-Induced Colitis in a Patient With Recurrent Metastatic Melanoma
    Moein, Hamid-Reza
    Rutledge, Brian
    Baydoun, Rafic
    Ehrinpreis, Murray N.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S934 - S934
  • [5] Ipilimumab and Nivolumab-Induced Colitis in a Patient With Recurrent Metastatic Melanoma
    Moein, Hamid-Reza
    Rutledge, Brian
    Beydoun, Rafic
    Ehrinpreis, Murray N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [6] Nivolumab-induced vitiligo in a metastatic melanoma patient: A case report
    Edmondson, Lindsay A.
    Smith, Leticia V.
    Mallik, Alka
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (08) : 629 - 634
  • [7] Ipilimumab- and Nivolumab-Induced Colitis Causing Severe Hypokalemia and QTc Prolongation
    Anson, David
    Norton, Joseph
    Chaucer, Benjamin
    Bansal, Saurabh
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2019, 2019
  • [8] A RARE CASE OF IPILIMUMAB/NIVOLUMAB-INDUCED MYOCARDITIS COMPLICATED BY HIGH GRADE ATRIOVENTRICULAR BLOCK IN A PATIENT WITH METASTATIC RENAL CELL CANCER
    Logiacco, A.
    Basile, P.
    Mandunzio, D.
    Gentile, M.
    Carella, M.
    Memeo, R.
    Santobuono, V
    Forleo, C.
    Ciccone, M.
    Guaricci, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2024, 26 : ii175 - ii175
  • [9] Ipilimumab/nivolumab/relatlimabHyperprogression of metastatic vaginal melanoma and myocarditis: case report
    Reactions Weekly, 2021, 1852 (1) : 248 - 248
  • [10] Ipilimumab/nivolumab-induced pseudolymphoma in a patient with malignant melanoma
    Ayoubi, Noura
    Haque, Adel
    Vera, Nora
    Ma, Sophia
    Messina, Jane
    Khushalani, Nikhil
    Seminario-Vidal, Lucia
    JOURNAL OF CUTANEOUS PATHOLOGY, 2020, 47 (04) : 390 - 393
12345